Do ACE Inhibitors/Angiotensin II Type 1 Receptor Antagonists Reduce Hospitalisations in Older Patients with Heart Failure?: A Propensity Analysis

By Trewet CoraLynn B.   Shireman Theresa I.   Rigler Sally K.   Howard Patricia A.  

Drugs & Aging, Vol. 24, Iss. 11, 2007-01 ,pp. : 945-955

Adis International

Access to resources Recommend Favorite

Can Angiotensin Receptor Antagonists Be Used Safely in Patients with Previous ACE Inhibitor-Induced Angioedema?

By Howes L.G.  

Drug Safety, Vol. 25, Iss. 2, 2002-01 ,pp. : 73-76

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of ACE Inhibitor Treatment for Patients with Type 1 Diabetes Mellitus

By Frederick B. Dong  

PharmacoEconomics, Vol. 22, Iss. 15, 2004-01 ,pp. : 1015-1027

Adis International

Access to resources Recommend Favorite

Effects of Olmesartan Medoxomil, an Angiotensin II Type 1 Receptor Antagonist, on Plasma Concentration of B-Type Natriuretic Peptide, in Hypertensive Patients with Type 2 Diabetes Mellitus: A Preliminary, Observational, Open-Label Study

By Kawai Toshihide   Takei Izumi   Shimada Akira  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 237-245

Adis International

Access to resources Recommend Favorite

Effect on the Atherogenic Marker Plasminogen Activator Inhibitor Type-1 of Addition of the ACE Inhibitor Imidapril to Angiotensin II Type 1 Receptor Antagonist Therapy in Hypertensive Patients with Abnormal Glucose Metabolism: A Prospective Cohort Study in Primary Care

By Yajima Ken   Shimada Akira  

Clinical Drug Investigation, Vol. 29, Iss. 12, 2009-12 ,pp. : 811-819

Adis International

Access to resources Recommend Favorite